Long‐term cost‐effectiveness of Dexcom G6 real‐time continuous glucose monitoring system in people with type 1 diabetes in Australia

INTRODUCTION: Real‐time continuous glucose monitoring (rt‐CGM) allows patients with diabetes to adjust insulin dosing, potentially improving glucose control. This study aimed to compare the long‐term cost‐effectiveness of the Dexcom G6 rt‐CGM device versus self‐monitoring of blood glucose (SMBG) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Isitt, J. J., Roze, S., Tilden, D., Arora, N., Palmer, A. J., Jones, T., Rentoul, D., Lynch, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research: Health Economics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310589/
https://www.ncbi.nlm.nih.gov/pubmed/35298036
http://dx.doi.org/10.1111/dme.14831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310589/
https://www.ncbi.nlm.nih.gov/pubmed/35298036
http://dx.doi.org/10.1111/dme.14831

Ejemplares similares